SCHEMBL2189096

SCHEMBL2189096

O=C(O)c1ccccc1NCC(O)CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
KDM4E B2RXH2 5/20 0.53
RAB9A P51151 2/20 0.53
AGTR1 P30556 1/20 0.53
POLB P06746 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
FABP4 P15090 2/20 0.46
FABP3 P05413 1/20 0.46
FABP5 Q01469 1/20 0.46
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.43
BACE1 P56817 1/20 0.43
APAF1 O14727 1/20 0.43
TDP2 O95551 1/20 0.43
CASP3 P42574 1/20 0.43
HKDC1 Q2TB90 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20195830 0.84 BACE1 (0.40) ALDH1A1HPGDHSD17B10KDM4ERAB9A
SCHEMBL28486884 0.83 HPGD (0.50) ALDH1A1HPGDHSD17B10KDM4ERAB9A
SCHEMBL8984846 0.81 ALDH1A1 (0.56) ALDH1A1HPGDHSD17B10KDM4ERAB9A
SCHEMBL1899470 0.79 KDM6B (0.62) ALDH1A1HPGDHSD17B10KDM4ERAB9A
SCHEMBL28496237 0.79 KDM4E (0.55) ALDH1A1HPGDHSD17B10KDM4EKMT2A
SCHEMBL9185142 0.79 ALDH1A1 (0.47) ALDH1A1HPGDHSD17B10KDM4ERAB9A
Phthalic Acid SCHEMBL28858619 0.78 ALDH1A1 (0.64) ALDH1A1HPGDHSD17B10KDM4EPOLB
Phthalic Acid SCHEMBL9417364 0.78 ALDH1A1 (0.64) ALDH1A1HPGDHSD17B10KDM4EPOLB
Phthalic Acid SCHEMBL120455 0.78 ALDH1A1 (0.64) ALDH1A1HPGDHSD17B10KDM4EPOLB
SCHEMBL6572484 0.77 FNTA (0.41) ALDH1A1RAB9AFABP4FABP3FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894017-B1 POLYMER BLEND FOR PERSONAL CARE FORMULATION DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-28 EP claimed
EP-3893836-B1 PERSONAL CARE FORMULATION COMPRISING A MULTISTAGE POLYMER WITH A CARBOSILOXANE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-28 EP claimed
EP-2827835-B2 SUPERABSORBENT POLYMERS AND SILICONE ELASTOMER FOR USE IN SKIN CARE COMPOSITIONS PROCTER & GAMBLE (US) 2022-09-07 EP claimed
EP-3164196-B1 TOPICAL FORMULATIONS FOR UV PROTECTION TOPGENIX INC (US) 2021-08-18 EP claimed
EP-2916814-B1 COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN COLABS INT CORPORATION (US) 2020-02-12 EP claimed
EP-2763749-B1 ENCAPSULATION OF PERSONAL CARE ACTIVES ROHM & HAAS (US) 2018-02-21 EP claimed
EP-3038594-B1 SUNSCREEN FORMULATIONS COMPRISING GEMINI SURFACTANTS AND SILICONE BASED SURFACTANTS AKZO NOBEL CHEMICALS INT BV (NL) 2017-08-02 EP claimed
EP-1181001-B1 SUNSCREEN COMPOSITION CONTAINING SOL-GEL MICROCAPSULES SOL GEL TECHNOLOGIES LTD (IL) 2011-07-13 EP claimed
EP-1608331-B1 SUNSCREEN COMPOSITION COMPRISING A MIXTURE OF SILICAS JOHNSON & JOHNSON IND LTDA (BR) 2007-11-07 EP claimed
EP-1092421-B1 Method for preparing ultraviolet radiation absorbing compositions ROHM & HAAS (US) 2007-03-21 EP claimed
EP-0761201-B1 Ultraviolet radiation absorption composition ROHM & HAAS (US) 2002-01-09 EP claimed
EP-0501714-B1 Cationic compositions for skin UNILEVER PLC (GB) 1997-05-02 EP claimed
EP-3310470-B1 USE OF AN AMPHOLYTE COPOLYMER AS COLLOIDAL STABILIZER SPCM SA (FR) 2020-03-04 EP disclosed
US-10406498-B2 Use of an ampholyte copolymer as colloidal stabilizer S.P.C.M. SA (FR) 2019-09-10 US disclosed
US-20180193812-A1 USE OF AN AMPHOLYTE COPOLYMER AS COLLOIDAL STABILIZER S.P.C.M. SA (FR) 2018-07-12 US disclosed
WO-2017163194-A1 SILK PIGMENT BASED COMPOSITION KUSURKAR TEJAS SANJEEV (IN) 2017-09-28 WO disclosed
WO-1997028784-A1 COMPOSITIONS USEFUL IN THE PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS ESTEE LAUDER INC. (US) 1997-08-14 WO disclosed
US-5556612-A APPLYING SUNSCREEN, WAITING FOR SKIN TO SLOUGH, ULTRAVIOLET RADIATION, TREATMENT OF PSORIASIS THE GENERAL HOSPITAL CORPORATION (US) 1996-09-17 US disclosed
US-5492894-A TRI TO HEXAPEPTIDE COTAINING ATLEAST THREE AMINO ACIDS IN THE FORM OF ARGANINE AND LYSINE FOR TOPICALLY APPLYING TO THE SKIN OF MAMMAL TO REGULATE WRINKLES THE PROCTER & GAMBLE COMPANY (US) 1996-02-20 US disclosed
EP-0000678-A1 Intermediate for synthesis: glycerylanthranilate and process for its preparation PIERRE FABRE S.A. (FR) 1979-02-07 EP disclosed